Exagen (XGN) PT Lowered to $10 at KeyBanc Amid ASP Headwinds
Tweet Send to a Friend
KeyBanc analyst Paul Knight lowered the price target on Exagen (NASDAQ: XGN) to $10.00 (from $15.00) while maintaining an Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
